Abstract
Post-Transplant Cyclophosphamide Is Associated with Improved Clinical Outcomes in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have